The Safety and Dose Response to Single Anal Doses of NRL001
NCT06593743
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Faecal Incontinence
Interventions
DRUG:
Perianal NRL001 Gel 3 strengths
DRUG:
Intraanal NRL001 Gel 2 strengths
DRUG:
Intrarectal NRL001 Gel
DRUG:
NRL001: 10mg suppository
Sponsor
Norgine